Skip to content
2000
image of Amarogentin, Natural Bitter Terpenoids: Research Update with Pharmacological Potential, Patent and Toxicity Aspects

Abstract

Amarogentin is a secoiridoid glycoside that was initially isolated from the medicinal plant Swertia chirayita. It is well-known for its formidable bitter characteristics and the varied pharmacological actions it possesses. Especially in both conventional and modern medical practices, this molecule has garnered considerable attention due to its enormous therapeutic potential. Amarogentin possesses a wide range of biological actions, some of which include functions that are hepatoprotective, anti-inflammatory, anti-cancer, anti-diabetic, and antibacterial. The hepatoprotective function it possesses is achieved by enhancing antioxidant defense systems and reducing liver damage caused by toxins. It is believed that the ability of amarogentin to block pro-inflammatory mediators, such as TNF-α and IL-6, is responsible for its anti-inflammatory properties. The stimulation of apoptosis and the reduction of cancer cell proliferation in various tumor models are two additional ways in which it demonstrates promising anti-cancer potential. The anti-diabetic activity of amarogentin is characterized by the modification of glucose metabolism as well as an improvement in insulin sensitivity. To enhance the therapeutic efficacy of amarogentin, further research is needed to investigate its bioavailability and stability in the human body. This is despite the fact that it possesses a wide range of pharmacological advantages. There are formulation options that could improve its pharmacokinetic profile. Some examples of these strategies are nanoparticle delivery systems and derivatization. In general, amarogentin exhibits a great deal of promise as a natural therapeutic agent for the treatment of liver diseases, cancer, and metabolic disorders. Accordingly, there is a need for further research into the mechanisms underlying its clinical applications and potential uses.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/ctmc/10.2174/0115680266392073250808110715
2025-08-21
2025-11-09

  • From This Site

    /content/journals/ctmc/10.2174/0115680266392073250808110715
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Ponticelli M. Lela L. Moles M. Mangieri C. Bisaccia D. Faraone I. Falabella R. Milella L. The healing bitterness of Gentiana lutea L., phytochemistry and biological activities: A systematic review. Phytochemistry 2023 206 113518 10.1016/j.phytochem.2022.113518 36423749
    [Google Scholar]
  2. Amarogentin 2025 Available from: https://www.chemicalbook.com/ChemicalProductProperty_EN_CB1452325.htm
  3. Roudnitzky N. Behrens M. Engel A. Kohl S. Thalmann S. Hübner S. Lossow K. Wooding S.P. Meyerhof W. Receptor polymorphism and genomic structure interact to shape bitter taste perception. PLoS Genet. 2015 11 9 1005530 10.1371/journal.pgen.1005530 26406243
    [Google Scholar]
  4. Amarogentin. 2025 Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Amarogentin
  5. Shukla S. Bafna K. Sundar D. Thorat S.S. The bitter barricading of prostaglandin biosynthesis pathway: Understanding the molecular mechanism of selective cyclooxygenase-2 inhibition by amarogentin, a secoiridoid glycoside from Swertia chirayita. PLoS One 2014 9 3 90637 10.1371/journal.pone.0090637 24603686
    [Google Scholar]
  6. Fiorito S. Epifano F. Palumbo L. Collevecchio C. Mascioli F. Spogli R. Genovese S. Leaves of yellow gentian (Gentiana lutea) as an alternative source of bitter secoiridoid glycosides. J. Nat. Prod. 2022 85 9 2232 2235 10.1021/acs.jnatprod.2c00529 36001997
    [Google Scholar]
  7. Gupta R. Sood H. Optimizing nutrient media conditions for continuous production of shoot biomass enriched in major medicinal constituents, amarogentin and mangiferin of endangered medicinal herb, Swertia chirayita. Vegetos 2022 36 3 833 841 10.1007/s42535‑022‑00464‑6 36061345
    [Google Scholar]
  8. Padhan JK Chauhan RS Sood H Understanding Biosynthesis of Major Chemical Constituents in Swertia chirayita Doctoral dissertation Jaypee University of Information Technology 2020
    [Google Scholar]
  9. Disasa D. Cheng L. Manzoor M. Liu Q. Wang Y. Xiang L. Qi J. Amarogentin from Gentiana rigescens Franch exhibits antiaging and neuroprotective effects through antioxidative stress. Oxid. Med. Cell. Longev. 2020 2020 1 1 15 10.1155/2020/3184019 32831994
    [Google Scholar]
  10. Zhang L. Ulriksen E.S. Hoel H. Sandvik L. Malterud K.E. Inngjerdingen K.T. Inngjerdingen M. Wangensteen H. Phytochemical characterization and anti-inflammatory activity of a water extract of Gentiana purpurea roots. J. Ethnopharmacol. 2023 301 115818 10.1016/j.jep.2022.115818 36220509
    [Google Scholar]
  11. Shubham S. Uma Bhardwaj U.B. Abhishek Mathur A.M. Isolation and identification of amarogentin as an antihelminthic compound in Swertia chirayta. J. Chem. Pharm. Res. 2016 8 4 1374 1381
    [Google Scholar]
  12. Kumar V. Chandra S. LC-ESI/MS determination of xanthone and secoiridoid glycosides from in vitro regenerated and in vivo Swertia chirayita. Physiol. Mol. Biol. Plants 2015 21 1 51 60 10.1007/s12298‑014‑0276‑9 25649848
    [Google Scholar]
  13. Khanal S. Shakya N. Thapa K. Pant D.R. Phytochemical investigation of crude methanol extracts of different species of Swertia from Nepal. BMC Res. Notes 2015 8 1 821 10.1186/s13104‑015‑1753‑0 26708007
    [Google Scholar]
  14. Sharma Y.P. Bhardwaj C. Sharma R. Thakur P. Sharma R. A new RP-HPLC method for simultaneous determination of amaroswerin, amarogentin and andrographolide in a herbal drug “Chirayata”. J. Chromatogr. Sci. 2023 61 2 172 176 10.1093/chromsci/bmac018 35253055
    [Google Scholar]
  15. Srivastava A. Srivastava N. Tiwari S. Srivastava S. Dutt B. Rawat A.K. Comparative phytochemical profiling in swertia species collected from different geographical region of india using high performance liquid chromatography coupled with photodiode array detector and mass spectrometry (HPLC-PDA-MS) followed by antioxidant potential. J. Phytochemistry Biochem. 2018 2 105 2
    [Google Scholar]
  16. Kaur P. Kumar Pandey D. Gupta R.C. Dey A. Simultaneous microwave assisted extraction and HPTLC quantification of mangiferin, amarogentin, and swertiamarin in Swertia species from Western Himalayas. Ind. Crops Prod. 2019 132 449 459 10.1016/j.indcrop.2019.02.055
    [Google Scholar]
  17. Chauhan R.S. Dutt P. Mangiferin, amaroswerin and amarogentin from Swertia alternifolia royle. J. Biol. Act. Prod Nat. 2012 2 2 104 109 10.1080/22311866.2012.10719116
    [Google Scholar]
  18. Kumar A. Sharma S. Quantitative determination of swertiamarin, mangiferin, and amarogentin in callus culture of Swertia chirata by HPLC analysis. J. Pharma Res. 2015 4 1270 1279
    [Google Scholar]
  19. Amakura Y. Yoshimura M. Morimoto S. Yoshida T. Tada A. Ito Y. Yamazaki T. Sugimoto N. Akiyama H. Chromatographic evaluation and characterization of components of gentian root extract used as food additives. Chem. Pharm. Bull. 2016 64 1 78 82 10.1248/cpb.c15‑00776 26726749
    [Google Scholar]
  20. Huang C. Li R. Zhang Y. Gong J. Amarogentin induces apoptosis of liver cancer cells via upregulation of p53 and downregulation of human telomerase reverse transcriptase in mice. Technol. Cancer Res. Treat. 2017 16 5 546 558 10.1177/1533034616657976 27402632
    [Google Scholar]
  21. Sakamoto S. Wada S. Tanaka H. Morimoto S. Sensitive quantitative analysis of the bitter glycoside amarogentin by specific monoclonal antibody-based indirect competitive enzyme-linked immunosorbent assay. RSC Advances 2018 8 31 17410 17416 10.1039/C8RA02922A 35539281
    [Google Scholar]
  22. Sharma N. Sharma A. Pant K. Ghai K. Pharmacognostic study and quantifiction of active component (Amarogentin) of Swertia Chirayita by HPLC. Int. J. Eng. Adv. Technol. 2020 8 4s 87 90 10.35940/ijeat.D1012.0484S19
    [Google Scholar]
  23. Sharma S. Sharma Y.P. Bhardwaj C. Mehta A. Quantification of amaroswerin and amarogentin in different parts of Swertia chirayita by chromatographic analysis. Int. Res. J. Pure Appl. Chem. 2019 17 4 1 7 10.9734/IRJPAC/2018/47081
    [Google Scholar]
  24. Mehta A. Rana R.C. Sharma Y.P. Sharma S. Comparative thin layer chromatographic evaluation of some Western Himalayan Swertia species. ICJ’S 2017 5 4 86 92
    [Google Scholar]
  25. Kshirsagar P.R. Aware C.B. Patil S.M. Bapat V.A. Optimization of extraction techniques and quantification of amarogentin by using RP-UFLC method from different Swertia species. Anal. Chem. Lett. 2019 9 3 373 384 10.1080/22297928.2019.1622449
    [Google Scholar]
  26. Wölfle U. Haarhaus B. Schempp C.M. Amarogentin displays immunomodulatory effects in human mast cells and keratinocytes. Mediators Inflamm. 2015 2015 1 630128 10.1155/2015/630128 26600671
    [Google Scholar]
  27. Zhang Y. Zhao H. Li H. Cao W. Wang F. Zhang T. Wang S.W. Protective effects of amarogentin against carbon tetrachloride-induced liver fibrosis in mice. Molecules 2017 22 5 754 10.3390/molecules22050754 28481234
    [Google Scholar]
  28. Tan Z. Wang W. Peng J. Zhou Z. Pan J. Peng A. Cao H. Fan W. Impact of amarogentin on gastric carcinoma cell multiplication, apoptosis and migration via circKIF4A/miR-152-3p. J. Immunol. Res. 2022 2022 1 1 9 10.1155/2022/2156204 35747689
    [Google Scholar]
  29. Pal D. Sur S. Roy R. Mandal S. Panda C.K. Hypomethylation of LIMD1 and P16 by downregulation of DNMT1 results in restriction of liver carcinogenesis by amarogentin treatment. J. Biosci. 2021 46 3 53 10.1007/s12038‑021‑00176‑0 34148876
    [Google Scholar]
  30. Zhang Q. Wang H. Ran C. Lyu Y. Li F. Yao Y. Xing S. Wang L. Chen S. Anti‐inflammatory effects of amarogentin on 2,4‐dinitrochlorobenzene‐induced atopic dermatitis–like mice and in HaCat cells. Animal Model. Exp. Med. 2023 6 3 255 265 10.1002/ame2.12260 36131559
    [Google Scholar]
  31. Cheng L. Osada H. Xing T. Yoshida M. Xiang L. Qi J. The insulin receptor: A potential target of amarogentin isolated from Gentiana rigescens Franch that induces neurogenesis in PC12 cells. Biomedicines 2021 9 5 581 10.3390/biomedicines9050581 34065446
    [Google Scholar]
  32. Song B. Zhou W. Amarogentin has protective effects against sepsis-induced brain injury via modulating the AMPK/SIRT1/NF-κB pathway. Brain Res. Bull. 2022 189 44 56 10.1016/j.brainresbull.2022.08.018 35985610
    [Google Scholar]
  33. Zhang Y. Zhang M. Li H. Zhao H. Wang F. He Q. Zhang T. Wang S. Serum metabonomics study of the hepatoprotective effect of amarogentin on CCl4-induced liver fibrosis in mice by GC-TOF-MS analysis. J. Pharm. Biomed. Anal. 2018 149 120 127 10.1016/j.jpba.2017.10.029 29112900
    [Google Scholar]
  34. Saha P. Mandal S. Das A. Das S. Amarogentin can reduce hyperproliferation by downregulation of Cox-II and upregulation of apoptosis in mouse skin carcinogenesis model. Cancer Lett. 2006 244 2 252 259 10.1016/j.canlet.2005.12.036 16517061
    [Google Scholar]
  35. Dai K. Yi X.J. Huang X.J. Muhammad A. Li M. Li J. Yang G.Z. Gao Y. Hepatoprotective activity of iridoids, seco-iridoids and analog glycosides from Gentianaceae on HepG2 cells via CYP3A4 induction and mitochondrial pathway. Food Funct. 2018 9 5 2673 2683 10.1039/C8FO00168E 29675530
    [Google Scholar]
  36. Pal D. Sur S. Roy R. Mandal S. Kumar Panda C. Epigallocatechin gallate in combination with eugenol or amarogentin shows synergistic chemotherapeutic potential in cervical cancer cell line. J. Cell. Physiol. 2019 234 1 825 836 10.1002/jcp.26900 30078217
    [Google Scholar]
  37. Yen T.L. Lu W.J. Lien L.M. Thomas P.A. Lee T.Y. Chiu H.C. Sheu J.R. Lin K.H. Amarogentin, a secoiridoid glycoside, abrogates platelet activation through PLC γ 2-PKC and MAPK pathways. BioMed Res. Int. 2014 2014 1 728019 10.1155/2014/728019 24868545
    [Google Scholar]
  38. Ma A. Wang J. Yang L. An Y. Zhu H. AMPK activation enhances the anti-atherogenic effects of high density lipoproteins in apoE−/− mice. J. Lipid Res. 2017 58 8 1536 1547 10.1194/jlr.M073270 28611100
    [Google Scholar]
  39. Potunuru U.R. Priya K.V. Varsha M.K.N.S. Mehta N. Chandel S. Manoj N. Raman T. Ramar M. Gromiha M.M. Dixit M. Amarogentin, a secoiridoid glycoside, activates AMP- activated protein kinase (AMPK) to exert beneficial vasculo-metabolic effects. Biochim. Biophys. Acta, Gen. Subj. 2019 1863 8 1270 1282 10.1016/j.bbagen.2019.05.008 31125678
    [Google Scholar]
  40. Li S. Li X. He F. Jiao R. Zhang S. Li Z. Amarogentin promotes osteoblast differentiation in oestrogen-deficiency-induced osteoporosis rats by modulating the Nrf-2/MAPK/ERK signalling pathway. Arch. Med. Sci. 2023 19 2 452 457 10.5114/aoms.2019.89652 37034504
    [Google Scholar]
  41. Samaddar T. Chaubey B. Jha S. Jha T.B. Determination of swertiamarin and amarogentin content and evaluation of antibacterial activity in Eastern Himalayan species of Swertia L. Pharmacogn. Commun. 2013 3 4 64 70 10.5530/pc.2013.4.9
    [Google Scholar]
  42. Patel K. Kumar V. Verma A. Rahman M. Patel D.K. Amarogentin as topical anticancer and anti-infective potential: Scope of lipid based vesicular in its effective delivery. Recent Patents Anti-Infect. Drug Disc. 2019 14 1 7 15 10.2174/1574891X13666180913154355 30210007
    [Google Scholar]
  43. Lee Tien-Li Oral pharmaceutical formulation for weight loss, diabetes and related disorders. US Patent 10835505B2 2018
  44. Composition for improving skin wrinkle containing amarogentin. KR Patent 101453190B1 2013
  45. Cosmetic composition for skin whitening, regeneration or moisturizing comprising amarogentin. KR Patent 101460901B1 2013
  46. A kind of method that Amberlyst process recovery semen armeniacae amarae takes off amarogentin in misery. CN Patent 107759644A 2017
  47. A kind of semen armeniacae amarae granule and its preparation and method of quality control. CN Patent 107271589A 2017
  48. Agonists of bitter taste receptors and uses thereof. US Patent 20100130498A1 2007
  49. Oral pharmaceutical formulations of bitter compounds for pulmonary hypertension. US Patent 20210260013A1 2019
  50. A method of optimization Taohe Chengqi decoction decoction preparation process. CN Patent 109223881A 2018
/content/journals/ctmc/10.2174/0115680266392073250808110715
Loading
Amarogentin, Natural Bitter Terpenoids: Research Update with Pharmacological Potential, Patent and Toxicity Aspects
Bentham Science Publishers ; https://doi.org/10.2174/0115680266392073250808110715
/content/journals/ctmc/10.2174/0115680266392073250808110715
/content/journals/ctmc/10.2174/0115680266392073250808110715
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: Cancer ; hepatoprotective ; secoiridoid glycoside ; tumor ; Gentiana species

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test